CIK 0001169445
TBRG TruBridge, Inc.
Insider trading from SEC Form 4. Last filing Nov 18, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Signals
Open-market buys and sells at TruBridge, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Michael Daughton Chief Business Officer buy | $999k 50,000 shares | +667% | - | |
| 30Weak | David Harse General Manager Patient Care sell | $48k 1,744 shares | -9% | - | |
| 28Weak | Vita MacIntyre Controller sell | $8,355 335 shares | -14% | - | |
| 37Weak | L6 Holdings Inc. owner buy | $1.9M 80,000 shares | +4% | - | |
| 37Weak | L6 Holdings Inc. owner buy | $1.7M 70,000 shares | +4% | - | |
| 44Moderate | Christopher L Fowler President and CEO sell | $150k 6,000 shares | -4% | - | |
| 40Moderate | L6 Holdings Inc. owner buy | $2.6M 96,607 shares | +5% | - | |
| 44Moderate | Christopher L Fowler President and CEO sell | $138k 5,100 shares | -3% | - | |
| 33Weak | Christopher L Fowler President and CEO buy | $179 16 shares | - | - | |
| 43Moderate | L6 Holdings Inc. owner buy | $3.3M 117,609 shares | +7% | - | |
| 48Moderate | Pinetree Capital Ltd. owner buy | $3.5M 124,858 shares | +17% | - | |
| 43Moderate | Pinetree Capital Ltd. owner buy | $3.1M 110,176 shares | +18% | - | |
| 24Weak | Mark Anquillare V director buy | $42k 2,500 shares | +17% | - |
Transactions
The last 46 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 11, 2025 | Michael Daughton Chief Business Officer | POpen-market purchase Common Stock | +15,479 | $19.39 | $300k | 22,971 | Nov 18, 2025 |
| Nov 12, 2025 | Michael Daughton Chief Business Officer | POpen-market purchase Common Stock | +10,167 | $19.95 | $203k | 33,138 | Nov 18, 2025 |
| Nov 13, 2025 | Michael Daughton Chief Business Officer | POpen-market purchase Common Stock | +4,354 | $20.16 | $88k | 37,492 | Nov 18, 2025 |
| Nov 14, 2025 | Michael Daughton Chief Business Officer | POpen-market purchase Common Stock | +2,500 | $20.15 | $50k | 39,992 | Nov 18, 2025 |
| Nov 17, 2025 | Michael Daughton Chief Business Officer | POpen-market purchase Common Stock | +17,500 | $20.46 | $358k | 57,492 | Nov 18, 2025 |
| Oct 15, 2025 | Michael Daughton Chief Business Officer | AGrant or award Common Stock | +7,492 | $0.00 | $0 | 7,492 | Oct 15, 2025 |
| Mar 14, 2025 | David Harse General Manager Patient Care | SOpen-market sale Common Stock | -1,744 | $27.40 | $48k | 18,058 | Aug 15, 2025 |
| May 20, 2025 | Vita MacIntyre Controller | SOpen-market sale Common Stock | -335 | $24.94 | $8,355 | 2,090 | Jul 28, 2025 |
| Jul 1, 2024 | Christopher L Fowler President and CEO | FTax withholding Common Stock | -1,508 | $10.57 | $16k | 129,582 | Jul 3, 2025 |
| Jul 1, 2025 | Christopher L Fowler President and CEO | FTax withholding Common Stock | -2,278 | $23.48 | $53k | 127,304 | Jul 3, 2025 |
| May 21, 2025 | L6 Holdings Inc. owner | POpen-market purchase Common stock, par value $0.001 per share ('Common Stock')indirect: See footnotes (3)(4)(5) | +40,000 | $24.30 | $972k | 1,965,000 | May 23, 2025 |
| May 21, 2025 | L6 Holdings Inc. owner | POpen-market purchase Common stock, par value $0.001 per share ('Common Stock')indirect: See footnotes (3)(4)(5) | +40,000 | $24.30 | $972k | 1,965,000 | May 23, 2025 |
| May 22, 2025 | L6 Holdings Inc. owner | POpen-market purchase Common stockindirect: See footnotes (3)(4)(5) | +15,000 | $23.98 | $360k | 1,980,000 | May 23, 2025 |
| May 22, 2025 | L6 Holdings Inc. owner | POpen-market purchase Common stockindirect: See footnotes (3)(4)(5) | +15,000 | $23.98 | $360k | 1,980,000 | May 23, 2025 |
| May 23, 2025 | L6 Holdings Inc. owner | POpen-market purchase Common stockindirect: See footnotes (3)(4)(5) | +15,000 | $24.01 | $360k | 1,995,000 | May 23, 2025 |
| May 23, 2025 | L6 Holdings Inc. owner | POpen-market purchase Common stockindirect: See footnotes (3)(4)(5) | +25,000 | $24.01 | $600k | 2,005,000 | May 23, 2025 |
| May 16, 2025 | Christopher L Fowler President and CEO | SOpen-market sale Common Stock | -6,000 | $25.05 | $150k | 131,090 | May 20, 2025 |
| Mar 19, 2025 | L6 Holdings Inc. owner | POpen-market purchase Common stock, par value $0.001 per share ('Common Stock')indirect: See footnotes (3)(4)(5) | +65,524 | $26.93 | $1.8M | 1,893,917 | Mar 21, 2025 |
| Mar 21, 2025 | L6 Holdings Inc. owner | POpen-market purchase Common Stockindirect: See footnotes (3)(4)(5) | +31,083 | $27.99 | $870k | 1,925,000 | Mar 21, 2025 |
| Mar 17, 2025 | Vinay Bassi Chief Financial Officer | FTax withholding Common Stock | -3,965 | $28.10 | $111k | 43,524 | Mar 18, 2025 |
| Mar 17, 2025 | David Harse General Manager Patient Care | FTax withholding Common Stock | -1,098 | $28.10 | $31k | 19,802 | Mar 18, 2025 |
| Mar 17, 2025 | Christopher L Fowler President and CEO | FTax withholding Common Stock | -5,849 | $28.10 | $164k | 137,090 | Mar 18, 2025 |
| Mar 14, 2025 | Christopher L Fowler President and CEO | SOpen-market sale Common Stock | -5,100 | $27.02 | $138k | 142,939 | Mar 17, 2025 |
| Mar 13, 2025 | Vinay Bassi Chief Financial Officer | AGrant or award Common Stock | +14,588 | $0.00 | $0 | 47,489 | Mar 14, 2025 |
| Mar 13, 2025 | David Harse General Manager Patient Care | AGrant or award Common Stock | +5,835 | $0.00 | $0 | 20,900 | Mar 14, 2025 |
| Mar 13, 2025 | Christopher T Hjelm director | AGrant or award Common Stock | +4,376 | $0.00 | $0 | 31,591 | Mar 14, 2025 |
| Mar 13, 2025 | Christopher L Fowler President and CEO | AGrant or award Common Stock | +22,611 | $0.00 | $0 | 148,039 | Mar 14, 2025 |
| Mar 13, 2025 | Jerry G Canada Jr. director | AGrant or award Common Stock | +4,376 | $0.00 | $0 | 4,376 | Mar 14, 2025 |
| Mar 13, 2025 | Regina M. Benjamin director | AGrant or award Common Stock | +4,376 | $0.00 | $0 | 38,687 | Mar 14, 2025 |
| Mar 13, 2025 | David A Dye director | AGrant or award Common Stock | +4,376 | $0.00 | $0 | 98,645 | Mar 14, 2025 |
| Mar 13, 2025 | Mark Anquillare V director | AGrant or award Common Stock | +4,376 | $0.00 | $0 | 21,554 | Mar 14, 2025 |
| Mar 7, 2025 | Christopher L Fowler President and CEO | FTax withholding Common Stock | -791 | $28.31 | $22k | 127,520 | Mar 11, 2025 |
| Mar 7, 2025 | Christopher L Fowler President and CEO | FTax withholding Common Stock | -2,092 | $28.31 | $59k | 125,428 | Mar 11, 2025 |
| Nov 14, 2023 | Christopher L Fowler President and CEO | POpen-market purchase Common Stockindirect: By spouse | +9 | $11.31 | $102 | 9 | Feb 27, 2025 |
| Nov 28, 2023 | Christopher L Fowler President and CEO | POpen-market purchase Common Stockindirect: By spouse | +5 | $10.90 | $55 | 14 | Feb 27, 2025 |
| Nov 29, 2023 | Christopher L Fowler President and CEO | POpen-market purchase Common Stockindirect: By spouse | +2 | $11.17 | $22 | 16 | Feb 27, 2025 |
| Feb 24, 2025 | L6 Holdings Inc. owner | POpen-market purchase Common stock, par value $0.001 per share ('Common Stock')indirect: See footnotes (3)(4)(5) | +30,377 | $28.28 | $859k | 1,741,161 | Feb 26, 2025 |
| Feb 25, 2025 | L6 Holdings Inc. owner | POpen-market purchase Common Stockindirect: See footnotes (3)(4)(5) | +87,232 | $28.09 | $2.5M | 1,828,393 | Feb 26, 2025 |
| Feb 19, 2025 | Pinetree Capital Ltd. owner | POpen-market purchase Common stock, par value $0.001 per share ('Common Stock')indirect: See footnotes (3)(4)(5) | +4,122 | $28.00 | $115k | 733,298 | Feb 21, 2025 |
| Feb 20, 2025 | Pinetree Capital Ltd. owner | POpen-market purchase Common Stockindirect: See footnotes (3)(4)(5) | +34,952 | $27.99 | $978k | 768,250 | Feb 21, 2025 |
| Feb 21, 2025 | Pinetree Capital Ltd. owner | POpen-market purchase Common Stockindirect: See footnotes (3)(4)(9) | +85,784 | $28.25 | $2.4M | 1,710,784 | Feb 21, 2025 |
| Feb 13, 2025 | Pinetree Capital Ltd. owner | POpen-market purchase Common stock, par value $0.001 per share ('Common Stock')indirect: See footnotes (3)(4)(5) | +74,981 | $27.61 | $2.1M | 693,981 | Feb 18, 2025 |
| Feb 14, 2025 | Pinetree Capital Ltd. owner | POpen-market purchase Common Stockindirect: See footnotes (3)(4)(5) | +28,400 | $27.99 | $795k | 722,381 | Feb 18, 2025 |
| Feb 18, 2025 | Pinetree Capital Ltd. owner | POpen-market purchase Common Stockindirect: See footnotes (3)(4)(5) | +6,795 | $28.16 | $191k | 729,176 | Feb 18, 2025 |
| Nov 25, 2024 | Mark Anquillare V director | POpen-market purchase Common Stock | +2,500 | $16.81 | $42k | 17,178 | Nov 25, 2024 |
| Oct 18, 2024 | Amy K O'Keefe director | AGrant or award Common Stock | +3,185 | $0.00 | $0 | 3,185 | Oct 28, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Mark Anquillare Vdirector
- Vinay BassiChief Financial Officer
- Regina M. Benjamindirector
- Jerry G Canada Jr.director
- David A Dyedirector
- Michael DaughtonChief Business Officer
- Christopher L FowlerPresident and CEO
- Christopher T Hjelmdirector
- David HarseGeneral Manager Patient Care
- L6 Holdings Inc.owner
- Vita MacIntyreController
- Amy K O'Keefedirector
- Pinetree Capital Ltd.owner
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.